Skip to main content

Peer Review reports

From: Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report

Original Submission
24 Jun 2019 Submitted Original manuscript
7 Nov 2019 Reviewed Reviewer Report - Takeo Kosaka
12 Nov 2019 Reviewed Reviewer Report - Alice P Chen
3 Dec 2019 Author responded Author comments - Andrew Simmons
2 Jan 2020 Reviewed Reviewer Report - Takeo Kosaka
14 Feb 2020 Author responded Author comments - Andrew Simmons
Resubmission - Version 2
3 Dec 2019 Submitted Manuscript version 2
Publishing
18 Feb 2020 Editorially accepted
14 Mar 2020 Article published 10.1186/s12885-020-6657-2

You can find further information about peer review here.

Back to article page